GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma A/S (OSTO:INIT) » Definitions » PB Ratio

Initiator Pharma A/S (OSTO:INIT) PB Ratio : 15.97 (As of Jun. 03, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Initiator Pharma A/S PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-03), Initiator Pharma A/S's share price is kr10.25. Initiator Pharma A/S's Book Value per Share for the quarter that ended in Mar. 2024 was kr0.64. Hence, Initiator Pharma A/S's PB Ratio of today is 15.97.

The historical rank and industry rank for Initiator Pharma A/S's PB Ratio or its related term are showing as below:

OSTO:INIT' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 34.35
Current: 15.97

During the past 8 years, Initiator Pharma A/S's highest PB Ratio was 34.35. The lowest was 0.00. And the median was 0.00.

OSTO:INIT's PB Ratio is ranked worse than
94.59% of 1313 companies
in the Biotechnology industry
Industry Median: 2.52 vs OSTO:INIT: 15.97

During the past 12 months, Initiator Pharma A/S's average Book Value Per Share Growth Rate was -9.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -21.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -8.40% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Initiator Pharma A/S was 20.60% per year. The lowest was -21.60% per year. And the median was 2.10% per year.

Back to Basics: PB Ratio


Initiator Pharma A/S PB Ratio Historical Data

The historical data trend for Initiator Pharma A/S's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Initiator Pharma A/S PB Ratio Chart

Initiator Pharma A/S Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial 13.51 6.75 7.37 6.31 28.97

Initiator Pharma A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.55 16.59 26.05 28.97 14.17

Competitive Comparison of Initiator Pharma A/S's PB Ratio

For the Biotechnology subindustry, Initiator Pharma A/S's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Initiator Pharma A/S's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma A/S's PB Ratio distribution charts can be found below:

* The bar in red indicates where Initiator Pharma A/S's PB Ratio falls into.



Initiator Pharma A/S PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Initiator Pharma A/S's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=10.25/0.642
=15.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Initiator Pharma A/S  (OSTO:INIT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Initiator Pharma A/S PB Ratio Related Terms

Thank you for viewing the detailed overview of Initiator Pharma A/S's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Initiator Pharma A/S (OSTO:INIT) Business Description

Traded in Other Exchanges
N/A
Address
Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma A/S is a clinical Stage Life Science company engaged in the research and development of various drugs targeting medical needs within the central and peripheral nervous system. The company's principal drug candidate is the IPED2015, a type of monoamine reuptake inhibitor (MRI) that has completed preclinical development for the treatment of erectile dysfunction in men. Its MRI drug candidates also include IPDP2015 for the treatment of depression; and IPNP2015 to treat neuropathic pain.

Initiator Pharma A/S (OSTO:INIT) Headlines

No Headlines